Enveric Biosciences, Inc. (ENVB) stock
ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.41−0.03 (-2.08%)
Close on Nov 17, 2026Market cap $6.31MP/E –Yield –
Enveric Biosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Enveric Biosciences's market cap was $5.86M on Nov 11, 2026, against $2.98M a year earlier. Over the last 5 years it ranged from $895.01K to $78.80B, with a median of $8.72B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.86M | +211.7% |
| 2025 | Dec 31, 2025 | $1.88M | -100.0% |
| 2024 | Dec 31, 2024 | $8.70B | +13.7% |
| 2023 | Dec 29, 2023 | $7.66B | -34.4% |
| 2022 | Dec 30, 2022 | $11.67B | -85.2% |
| 2021 | Dec 31, 2021 | $78.80B | +243.7% |
| 2020 | Dec 31, 2020 | $22.93B | -62.6% |
| 2019 | Dec 31, 2019 | $61.33B | +42.2% |
| 2018 | Dec 31, 2018 | $43.12B | -91.9% |
| 2017 | Dec 29, 2017 | $530.87B | -44.0% |
| 2016 | Dec 30, 2016 | $948.10B | +14.3% |
| 2015 | Dec 31, 2015 | $829.61B | – |
See a number that looks wrong?